Endocrinology Practice Questions

Q: Which of the following clinical problems is NOT associated with hypothyroidism?

Weight loss is associated with hypothyroidism.. Weight loss is associated with hypothyroidism. - Hypothyroidism is characterized by a **decreased metabolic rate**, leading to common symptoms like **weight gain** and difficulty losing weight [1]. - Therefore, **weight loss** is not a typical clinical problem associated with hypothyroidism; rather, it is often seen in hyperthyroidism [1]. *Menorrhagia is associated with hypothyroidism.* - Hypothyroidism can lead to **menorrhagia** (heavy menstrual bleeding) due to impaired coagulation factor synthesis and altered estrogen metabolism. - The **slowed metabolism** can affect the breakdown of estrogen, leading to prolonged endometrial stimulation. *Early abortions are associated with hypothyroidism.* - **Untreated hypothyroidism** in pregnant individuals is associated with an increased risk of **early pregnancy loss** and recurrent miscarriages. - This is thought to be due to an inadequate uterine environment and hormonal imbalances critical for a viable pregnancy. *Galactorrhoea is associated with hypothyroidism.* - Hypothyroidism can cause **hyperprolactinemia** due to increased **thyrotropin-releasing hormone (TRH)**, which stimulates prolactin release. - Elevated prolactin levels can lead to **galactorrhoea** (milk production unrelated to childbirth or breastfeeding).

Q: The commonest cause of primary hyperparathyroidism is what?

Solitary parathyroid adenoma. ***Solitary parathyroid adenoma*** - A **solitary parathyroid adenoma** is the cause of **80-85%** of primary hyperparathyroidism cases [2]. - This benign tumor leads to excessive parathyroid hormone (PTH) secretion, causing **hypercalcemia** [3]. *Parathyroid carcinoma* - **Parathyroid carcinoma** is a very rare cause of primary hyperparathyroidism, accounting for less than **1%** of cases. - While it also causes hypercalcemia, its clinical presentation is often more severe with significantly higher PTH and calcium levels, often with a palpable neck mass. *Chronic kidney disease* - **Chronic kidney disease** is a common cause of **secondary hyperparathyroidism**, not primary hyperparathyroidism [2]. - In secondary hyperparathyroidism, low calcium and vitamin D levels (due to impaired kidney function) stimulate the parathyroid glands to produce more PTH [1], [2]. *Parathyroid hyperplasia* - **Parathyroid hyperplasia**, involving enlargement of all four parathyroid glands, accounts for about **10-15%** of primary hyperparathyroidism cases. - It is the second most common cause after solitary adenomas, but still less frequent.

Q: Which of the following is a common laboratory finding in hypothyroidism?

High TSH. ### High TSH - In **primary hypothyroidism**, the thyroid gland fails to produce adequate thyroid hormones (**T3** and **T4**). [1] - This leads to a compensatory increase in **TSH** release from the pituitary gland, attempting to stimulate the thyroid. [1] *Low T3* - While **low T3** can be present in hypothyroidism, **low free T4** is generally a more sensitive and specific marker for the diagnosis of primary hypothyroidism. [1] - T3 levels can sometimes remain normal or only slightly reduced even in overt hypothyroidism, especially in the early stages. *High cholesterol* - **Elevated cholesterol**, particularly **LDL (low-density lipoprotein)**, is a common metabolic consequence of hypothyroidism due to decreased catabolism of lipids. [2] - However, it is a metabolic complication rather than a direct hormonal lab finding defining hypothyroidism. *High Triglycerides* - **High triglycerides** can also be observed in hypothyroidism due to impaired lipid metabolism and reduced lipoprotein lipase activity. - Similar to elevated cholesterol, it is a metabolic consequence, not a primary diagnostic marker for the thyroid hormone imbalance itself.

Q: Which of the following is not a marker for hyperparathyroidism?

Alteration in serum calcitonin levels. ***Alteration in serum calcitonin levels*** - While calcitonin plays a role in calcium regulation, its levels are generally **not directly altered** in primary hyperparathyroidism. - Calcitonin is secreted by **parafollicular C cells of the thyroid gland** and acts to lower plasma calcium, *Increase in serum calcium* - **Hypercalcemia** is a hallmark of primary hyperparathyroidism, as excess PTH mobilizes calcium from bones and increases renal reabsorption [2]. - Prolonged elevation can lead to symptoms like **"stones, bones, groans, and psychic overtones"** [1]. *Increase in serum parathyroid hormone (PTH) levels* - An **elevated PTH level** is the primary diagnostic criterion for primary hyperparathyroidism [1]. - This indicates an overactive parathyroid gland, which is responsible for **regulating calcium homeostasis**. *Subperiosteal bone resorption of phalanges* - This is a classic radiographic finding in advanced **primary hyperparathyroidism**, particularly in the **distal phalanges**. - It results from the continuous action of **excess PTH on osteoclasts**, leading to bone breakdown [1].

Q: Middle-aged female with a mass in the sella turcica, what is the hormone level that is increased?

Prolactin. ***Prolactin*** - A mass in the **sella turcica** suggests a **pituitary adenoma**, and the most common type is a **prolactinoma** [1]. - **Prolactinomas** cause an elevation in **prolactin levels**, leading to symptoms like galactorrhea, amenorrhea, and infertility in women [1]. *Thyroxine* - An increase in **thyroxine** usually indicates **hyperthyroidism**, which results from thyroid gland dysfunction or a TSH-secreting pituitary adenoma, not typically a mass directly causing elevated thyroxine. - While TSH-secreting adenomas are rare causes of thyrotoxicosis, a non-functional or prolactin-secreting pituitary mass would not directly increase peripheral thyroxine levels [2]. *ADH* - **Antidiuretic hormone (ADH)**, also known as vasopressin, is primarily involved in water balance. - While ADH can be affected by pituitary lesions, an increase would typically lead to **syndrome of inappropriate ADH secretion (SIADH)**, causing hyponatremia, which is not the primary presentation for most sella turcica masses. *Estrogen* - **Estrogen** levels are regulated by the ovaries under the influence of FSH and LH from the pituitary. - While pituitary masses can affect gonadotropin secretion (FSH/LH), leading to changes in estrogen, the mass itself does not directly secrete estrogen.

Q: Multiple submucosal neuromas are most likely associated with:

Multiple endocrine neoplasia type 2B. ***Multiple endocrine neoplasia type 2B*** - Multiple submucosal neuromas, particularly in the lips, tongue, and gastrointestinal tract, are a **hallmark feature** of MEN2B. - This syndrome is also characterized by **medullary thyroid carcinoma** and **pheochromocytoma**, often with a marfanoid habitus. *Ovarian germ cell tumor* - These tumors arise from **germ cells** in the ovary and include types such as dysgerminomas, teratomas, and yolk sac tumors. - They are not associated with the development of **submucosal neuromas**. *Testicular seminoma* - A type of **germ cell tumor** originating in the testes, which can produce HCG or LDH. - This condition has no known association with the development of **multiple submucosal neuromas**. *Pancreatic neuroendocrine tumor* - These tumors arise from the **endocrine cells** of the pancreas and can be functional (e.g., insulinoma, gastrinoma) or non-functional. - While they are endocrine tumors, they do not present with **submucosal neuromas**.

Q: In a patient presenting with diabetic ketoacidosis (DKA), what is the most appropriate immediate treatment?

Administration of insulin. ***Administration of insulin*** - **Insulin therapy** is critical in DKA to reverse the underlying metabolic abnormalities by stopping ketogenesis and facilitating glucose uptake into cells [1]. - It is typically administered intravenously at a continuous rate, after initial **fluid resuscitation**, to gradually lower blood glucose and resolve acidosis [1]. *Administration of an oral hypoglycemic agent* - **Oral hypoglycemic agents** are ineffective in DKA because these patients typically have an absolute or relative **insulin deficiency** and **profound insulin resistance** due to stress hormones [3]. - Moreover, they are not suitable for acutely ill patients who may have impaired gastrointestinal absorption. *Administration of bicarbonate* - **Bicarbonate administration** is generally not recommended in DKA unless the **pH is extremely low** (e.g., < 6.9 or 7.0) due to potential risks like paradoxical central nervous system acidosis and fluid overload. - The acidosis usually resolves with **insulin therapy** and **fluid resuscitation** as ketone body production ceases and they are metabolized [1]. *Close observation only* - **Diabetic ketoacidosis** is a medical emergency requiring urgent and aggressive intervention, not just observation [2]. - Delaying treatment can lead to severe complications, including **cerebral edema**, **coma**, and **death** [2].

Q: The triad of diabetes, gallstones, and steatorrhea is associated with which of the following?

Somatostatinomas. ***Somatostatinomas*** - This **triad** is characteristic of a somatostatinoma, as somatostatin inhibits insulin release, gallbladder contraction, and pancreatic enzyme secretion. - The inhibition of **insulin release** leads to diabetes [1], blocked **cholecystokinin (CCK)** release causes gallstones, and reduced **pancreatic enzyme** secretion results in steatorrhea. *Gastrinomas* - Gastrinomas typically cause **Zollinger-Ellison syndrome**, characterized by severe peptic ulcers and diarrhea due to excessive acid production. - They are not directly associated with the specific triad of diabetes, gallstones, and steatorrhea. *VIPomas* - VIPomas are known for causing **Verner-Morrison syndrome** or pancreatic cholera, leading to severe watery diarrhea, hypokalemia, and achlorhydria. - Diabetes and gallstones are not prominent features of VIPomas. *Glucagonomas* - Glucagonomas primarily manifest with **diabetes** (due to elevated glucagon), a characteristic skin rash called **necrolytic migratory erythema**, and weight loss [1]. - While diabetes is present, gallstones and steatorrhea are not typical associations.

Q: What is the first-line drug used for painful diabetic neuropathy?

Duloxetine. ***Duloxetine*** - **Duloxetine**, a serotonin-norepinephrine reuptake inhibitor (SNRI), is recommended as a **first-line agent** for the management of **painful diabetic neuropathy**. - Its efficacy in reducing neuropathic pain has been demonstrated in multiple clinical trials, leading to its approval for this indication. *Carbamazepine* - **Carbamazepine** is an **antiepileptic drug** primarily used for seizure disorders and trigeminal neuralgia, but it is not a first-line treatment for painful diabetic neuropathy. - While it can be used for neuropathic pain, its efficacy in diabetic neuropathy is **limited**, and it has a narrower therapeutic index with potential for significant adverse effects. *Venlafaxine* - **Venlafaxine** is another SNRI, similar to duloxetine, and can be used for neuropathic pain. However, **duloxetine** is generally preferred as a first-line agent specifically for **diabetic neuropathy** due to more robust evidence and specific FDA approval for this indication. - While it has similar mechanisms of action, it is often considered a **second-line** or alternative agent for painful diabetic neuropathy. *EMLA cream* - **EMLA cream** (eutectic mixture of local anesthetics) contains lidocaine and prilocaine and is a **topical agent** used for localized pain or before minor procedures. - It is **not suitable for diffuse or widespread neuropathic pain**, such as that seen in painful diabetic neuropathy, and would not be considered a first-line systemic treatment.

Q: The best marker for hyperthyroidism is

TSH. ***TSH*** - **TSH (Thyroid-Stimulating Hormone)** is the most sensitive and specific initial test for evaluating thyroid function. - In **hyperthyroidism**, the thyroid gland produces excess thyroid hormones (T3 and T4), which suppresses TSH release from the pituitary gland, leading to **very low or undetectable TSH levels**. *T3* - While **elevated T3 levels** are diagnostic of hyperthyroidism, TSH is a more sensitive initial screen. - Some patients, particularly those with **T3 toxicosis**, may have elevated T3 but normal T4. *T4* - **Elevated T4 levels** are a key indicator of hyperthyroidism, but TSH often reflects changes in thyroid hormone status earlier and is more sensitive for screening. - **Free T4** is preferred over total T4 as it is not affected by protein binding changes. *Thyroglobulin* - **Thyroglobulin** is a protein produced by the thyroid gland and is primarily used as a **tumor marker** in patients with differentiated thyroid cancer after thyroidectomy. - It is **not a primary diagnostic marker for hyperthyroidism**, although it can be elevated in conditions causing thyroid destruction or inflammation.

Question 1

Which of the following clinical problems is NOT associated with hypothyroidism?

Accepted Answer

Weight loss is associated with hypothyroidism.

Answer

Early abortions are associated with hypothyroidism.

Answer

Galactorrhoea is associated with hypothyroidism.

Answer

Menorrhagia is associated with hypothyroidism.

Question 2

The commonest cause of primary hyperparathyroidism is what?

Accepted Answer

Solitary parathyroid adenoma

Answer

Parathyroid carcinoma

Answer

Chronic kidney disease

Answer

Parathyroid hyperplasia

Question 3

Which of the following is a common laboratory finding in hypothyroidism?

Accepted Answer

High TSH

Answer

Low T3

Answer

High cholesterol

Answer

High Triglycerides

Question 4

Which of the following is not a marker for hyperparathyroidism?

Accepted Answer

Alteration in serum calcitonin levels

Answer

Increase in serum parathyroid hormone (PTH) levels

Answer

Subperiosteal bone resorption of phalanges

Answer

Increase in serum calcium

Question 5

Middle-aged female with a mass in the sella turcica, what is the hormone level that is increased?

Accepted Answer

Prolactin

Answer

Thyroxine

Answer

ADH

Answer

Estrogen

Question 6

Multiple submucosal neuromas are most likely associated with:

Accepted Answer

Multiple endocrine neoplasia type 2B

Answer

Ovarian germ cell tumor

Answer

Testicular seminoma

Answer

Pancreatic neuroendocrine tumor

Question 7

In a patient presenting with diabetic ketoacidosis (DKA), what is the most appropriate immediate treatment?

Accepted Answer

Administration of insulin

Answer

Administration of an oral hypoglycemic agent

Answer

Administration of bicarbonate

Answer

Close observation only

Question 8

The triad of diabetes, gallstones, and steatorrhea is associated with which of the following?

Accepted Answer

Somatostatinomas

Answer

VIPomas

Answer

Gastrinomas

Answer

Glucagonomas

Question 9

What is the first-line drug used for painful diabetic neuropathy?

Accepted Answer

Duloxetine

Answer

Venlafaxine

Answer

EMLA cream

Answer

Carbamazepine

Question 10

The best marker for hyperthyroidism is

Accepted Answer

TSH

Answer

T3

Answer

T4

Answer

Thyroglobulin

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?